enocitabine has been researched along with Blast Crisis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, S; Hirai, H; Honda, H; Kanda, Y; Yazaki, Y | 1 |
| Chiba, S; Kikuchi, M; Misago, M; Mori, N; Nagata, K; Nakata, K; Oda, S; Otani, H; Sato, T; Tsukada, J | 1 |
1 review(s) available for enocitabine and Blast Crisis
| Article | Year |
|---|---|
Long-term third chronic phase of chronic myelogenous leukemia maintained by interferon-alpha and methotrexate.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Etoposide; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Methotrexate; Mitoxantrone; Remission Induction; Time; Treatment Outcome | 1999 |
1 other study(ies) available for enocitabine and Blast Crisis
| Article | Year |
|---|---|
[Successful treatment with a small dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in a case of chronic myelomonocytic leukemia in blastic crisis].
Topics: Antineoplastic Agents; Blast Crisis; Cytarabine; Female; Humans; Leukemia, Myelomonocytic, Chronic; Middle Aged; Remission Induction | 1989 |